A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer

Charalampos S. Floudas, Gagandeep Brar, Donna Mabry‐Hrones, Austin G. Duffy, Bradford J. Wood, Elliot Levy, Venkatesh Krishnasamy, Suzanne Fioravanti, Cecilia Monge Bonilla, Melissa Walker, Maria Pia Morelli, David E. Kleiner, Seth M. Steinberg, William D. Figg, Tim F. Greten, Changqing XieClinical 2019 · DOI

BibTeX
@inproceedings{floudas2019pilot,
  author = {Charalampos S. Floudas and Gagandeep Brar and Donna Mabry‐Hrones and Austin G. Duffy and Bradford J. Wood and Elliot Levy and Venkatesh Krishnasamy and Suzanne Fioravanti and Cecilia Monge Bonilla and Melissa Walker and Maria Pia Morelli and David E. Kleiner and Seth M. Steinberg and William D. Figg and Tim F. Greten and Changqing Xie},
  title = {{A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer}},
  booktitle = {Clinical},
  year = {2019},
  doi = {10.1016/j.clcc.2019.06.004},
}

Loading related content...

Figure